NasdaqGM:ALVOBiotechs
Alvotech (ALVO) Is Up 34.6% After FDA Clears Reykjavik Plant And BLAs Advance - Has The Bull Case Changed?
Alvotech recently reported that the FDA has closed its May 2026 inspection of the Reykjavik manufacturing facility with a Voluntary Action Indicated classification, confirming that the company’s corrective actions have addressed earlier observations and allowing it to keep advancing multiple Biologics License Applications in the US.
This resolution, alongside the resubmission or acceptance of BLAs for biosimilars to Simponi, Eylea and Entyvio, strengthens the company’s regulatory footing in...